Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation

IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation

US Patent 8592456 · Granted Nov 26, 2013

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for targeting, editing, or modifying genes2025
Compositions and methods for targeting, editing, or modifying genes2025
IL-17 and IFN-gamma inhibition for the treatment of autoimmune diseases and chro2022
IL-17 and IFN-gamma inhibition for the treatment of autoimmune diseases and chro2022
3-amino-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones as cyclin dependent kinase i2021
KV1.3 inhibitors and their medical application2020
Kv1.3 inhibitors and their medical application2020
Method of inhibiting DYRK1B2020
Method of inhibiting DYRK1B2020
Kv1.3 inhibitors and their medical applications2019
Heterocyclic compounds with working memory enhancing activity2019
2,3-dihydrobenzofuran-5YL compounds as DYRK kinase inhibitors2018